Description
| Speciality | ARAVEN | 
|---|---|
| Dosage | 150 mg | 
| Form | Film-coated tablet | 
| Packaging | Box of 30 | 
| Primary packaging | Blister | 
| Specification | Opaque PVC/PVDC/ALU | 
| INN (International Nonproprietary Name) | IRBESARTAN | 
| VEIC classification | Essential | 
| Therapeutic class | CARDIOVASCULAR SYSTEM | 
| Sub-class | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | 
| Laboratory | PHILADELPHIA PHARMA | 
| Schedule | A | 
| Shelf life | 24 months | 
| Generic/Brand | Generic | 
| Marketing Authorization Number | 9353041 | 
| Marketing Authorization Date | 2014-03-14 | 
| Range | Cardio-Metabolic Range | 







Reviews
There are no reviews yet.